Online presenation on the Roche tominersen programme

20th January 2022 @ 5:00 pm – 6:00 pm

This online meeting, hosted by EHDN, is geared towards a professional audience.

The meeting will include key findings from the Phase III GENERATION HD1 trial, followed by Q&A, then a
panel discussion with recognised experts in the field of HD. The meeting will last approximately 90 minutes.

Register here